ALK inhibitor 1

inquiry

Cat No.

CEI-1205

Product Overview

ALK inhibitors are potential anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation. ALK inhibitor 1 is a novel and selective inhibitor for the ALK kinase. Clinical trial: ALK inhibitor 1 is currently in the preclinical developlent stage and no clinical data are available.

CAS_No

761436-81-1

Molecular Weight

562.48

Purity

0.98

Storage

Store at -20°C

Targets

ALK

Molecular Formula

C23H28BrN7O3S

Chemical Name

2-[[5-bromo-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]-N-methylbenzenesulfonamide

Solubility

Soluble in DMSO

Shipping Conditions

Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request

In vitro

ALK inhibitor 1 (2-[[5-bromo-2-[2-methoxy-4-(4-methylpiperazin-1-yl) anilino]pyrimidin-4-yl] amino]-N-methylbenzenesulfonamide) is a chemical analogue of LDK378 that is a potent ALK inhibitor.

In vivo

No animal in-vivo data available currently.

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry